Industries de la santé
Biogaran takes over Swipha’s activities in Nigeria to produce quality generic medicines for the local market
![Envoyer](/templates/yoo_flux/images/emailButton.png)
![Imprimer](/templates/yoo_flux/images/printButton.png)
![PDF](/templates/yoo_flux/images/pdf_button.png)
27 Mars 2017
A strong commitment to make quality, accessible, affordable medicines available to patients |LAGOS, Nigeria, March 24, 2017/ -- Biogaran (www.Biogaran.fr), a French pharmaceutical company specialized in generic and biosimilar medicines, and a subsidiary of Servier (www.Servier.com), today announced the takeover of all the activities of Swipha, a Nigerian company that manufactures and...
Plus d'articles...
- CryoCapCell annonce une publication dans Nature Methods sur son logiciel eC-CLEM
- As fatty liver disease prevalence soars, pharma companies look to first-in-class drugs
- Pharnextannonce l'initiation de l'étude clinique d'extension de Phase 3 PLEO-CMT-FU de PXT3003 dans la maladie de Charcot-Marie-Tooth de type 1A
- DBV Technologies Résultat financiers 2016